Anifrolumab Real-world Treatment Outcomes in Systemic Lupus Erythematosus

NCT06673043 · clinicaltrials.gov ↗

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Erythematosus, Systemic

Interventions

DRUG: Anifrolumab

Sponsor

AstraZeneca